AU9144501A - Antifungal composition containing beta-(1,6)-glucanase and hosts incorporating same - Google Patents

Description

AUSTRALIA

Patents Act COMPLETE SPECIFICATION

(ORIGINAL)

Class Int. Class Application Number: Lodged: Complete Specification Lodged: Accepted: Published: Priority Related Art: a a Name of Applicant: Mogen International N.V.

Actual Inventor(s): Maarten Hendrik Stuiver, Wessel Lageweg, Johanna Pieternella Els Van Deventer-Troost, Jerome Hubertus Henricus Victor Custers Address for Service: PHILLIPS ORMONDE FITZPATRICK Patent and Trade Mark Attorneys 367 Collins Street Melbourne 3000 AUSTRALIA Invention Title: ANTIFUNGAL COMPOSITION CONTAINING BETA-(1,6)-GLUCANASE AND HOSTS INCORPORATING SAME Our Ref 657219 POF Code: 455473/325678 The following statement is a full description of this invention, including the best method of performing it known to applicant(s): -1- ANTIFUNGAL COMPOSITION CONTAINING BETA-(1,6)-GLUCANASE AND HOSTS INCORPORATING SAME This application is a divisional from parent application 77608/98, the entire content of which is incorporated herein by reference.

FIELD OF INVENTION The present invention relates to a novel glucanase proto~n. a combination of antifungal proteins and plants transtormqd W!Lh the giucanase or the combination, as well as methods of combattirng funqal pathogens by causing said funaal pathogens to bc contacted with said protein or proteins.

The invention further relates to transformed plants which show reduced susceptibility to fungal pathogens.

BACKGROUND ART A protein with antifungal activity, isolated from TXV-:rnduced tobacco leaves, which is capable of causing lysis of aerminatang spores and hyphal tips of ihycophthcra infestans and causes the hyphae to grow at a reduced rate, was disclosed in 0'.8P Al and in Woloshuk et al. (Plant cell 1, 619-628. 1991) This protein, an osmotill, has an apparent molecular weight of aboiut 24 kDa and was named AP24. Comparison of its complete amino acid sequence, as deduced from the nucleic acid sequence ot the AP24 gene, with~ proteins known from databases revealed that the protein was an osmotin-like protein.

It has further been known that combination of antifunaal agents such as chitinase and l9-(.3)-glucanase (EP-A 0 440 304) have a synergistic effect on the ability to destroy tunaa: pathogens.

Recently (Lorito et al., Mol. Plant-Macrob. Int. 206- 213, 1996) it has bepn ohou.m iflaL also coribinat-,ons cf osmo::-n and other antifungal agents are effective.

~WO 9t)/jS3 describes the f-(l6)-glucanase (or pustulanasei from Trichoderia harzianum as an agent which catalyzes thr clcavage: *Of 9-(1.6)-linkages 'n 9-olucan, a major comPonent r.f the cell walls of fungal cells. It has also been found to act cooperat~vally with cellulases and chitinases against fungal plant pathogens such.

35 as Botrytis, Phytophthora and Gibberella fujikori (de la Cruz, 3.

Bacteriol 177U (7 1864-1871. 1995) Despite initial success in combating func al pathoqens, and the genetic engineering of plants capable of producing these antifungal proteins with activity against fungal pathogens there remains a need to identify and isolate other proteins and/or synerqistic combinations with antifungal activity.

I SUMMARY OF THE INVENTION The present invention provides for a new protein w1ith (1.6)-glucanase activity isolated from an edible fungus. More specifically the invention describes methods to isolate such a protein.

The present invention further provides an antifungal composition comprising a 9-(1,6)-glucanase and optionally an osmotin.

The present invention further provides a method for making plants pathogen resistant by transforming them with recombinant

DNA

comprising a sequence coding for an osmotin and a sequence coding for a G-(1,6)-glucanase.

More specifically the osmotin is AP24. preferably having the amino acid sequence of SEQ ID NO:2. and preferably encoded by the nucleotide sequence of SEQ 3D NO:1.

More specifically the -(1.6)-glucanase is of fungal origin.

for instance from Trichodcrma harzianum, or from edible fungi such as mushroom or shii-take.

The invention also provides a recombinant DNA sequence according to the iovention further comprising a transcriptional 25 initiation region and, optionally, a transcriptional termination *o region, so linked to said open reading frames as to enable the DNA to be transcribed in a living host cell when present therein.

thereby producing RNAs which comprise said open reading frames.

preferred chimeric DNA sequence according to the invention :n one.

30 wherein 4he RNAs comprising said open reading frames are capable of being translated into protein in said host cell, when present therein, thereby producing said proteins.

The invention also embraces a chimeric DNA sequence comprising a DNA sequence according to the invention, which may be 35 selected from replicons, such as bacterial cloning plasmids and vectors, such as a bacterial expression vector, a (non-integrative) plant viral vector, a Ti-plasmid vector of Agrobacteriu. such as a binary vector, and the like, as well as a host cell comprising a i replicon or vector according to the invention, and which is capable of maintaining said replicon once present therein. Preferred according to tha" embodiment is a host cell which is a plant cell.

said vector bel... a non-integrative viral vector.

The invention further provides a host cell stably incorporating in its genome a chimeric DNA sequence according to the invention, such as a plant cell, as well as multicellular hos::; comprising such cells, or essentially consisting of such cells.

such as plants. Especially preferred are plants characterised in that the chimeric DNA according to the invention is expressed in at least a number of the plant's cells causing the said antitungal .proteins to be produced therein.

According to yet another embodiment of the invention a :nethod for producing a protein with i-(1,6)-glucanase activity i; provided, characterised in that a host cell according t.e the invention is grown under conditions allowing the said proe:: produced by said host cell. optionally followed by the step of recovering the protein from the host cells.

Another part of the invention is directed to the targetin.: of the osmotin and/or the 6-(1.6)-glucanase to the extracellular space.

The invention also provides a method for obtaining plants with reduced susceptibility to fungi, comprising the steps of o(a) introducing into ancestor cells which are susceptible of regeneration into a whole plar..

a chimeric DNA sequence comprising open reading frames capable of encoding an osmotin and a 9-(l,6)-glucanase, said open reading frames being operatively linked to one or more transcriptional and translational regions and, cptionally, a 30o transcriptional termination region, allowing the said proteinr. to be produced in a plant cell that is susceptible to intection by said fungus, and a chimeric DNA sequence capable of encoding a plant selectable marker allowing selection of transformed ancestor cells when said selectable marker is present therein, and regenerating said ancestor cells into plants under cond:tions favouring ancestor cells which have the said selectable marker, and identifying a plant which produces the proteins. thereby reducing the susceptibility of said plant to infection.

Preferred according to the invention is a method characterised in that stop is performed using an Agrobacterium tumcfaciens strain capable of T-DNA transfer to plant cell:; and which harbours the said chimeric DNA cloned into binary vector pMOG800: another preferred method is when step performed in the presence of an antibiotic favouring cells which have a ncomycin phosphotransferase or a cyanamid hydratase gene.

Legends to the figures.

Figure I. Purification of E1-6 glucanase by cation exchange chromatography. Three peaks of 1--6 glucanase activity can be seen.

indicated by the numbers 1, 2, and 3 respectively. The chromatogram of one representative run is shown. Other runs showed simnilar. it not identical, protein patterns and distribution of fl-6 gluc:anas,; activity. Protein is measured at A280. V1-6 glucanase activity :s measured as described and is depicted as the absorbance at 510 nanometre.

Figure 2. Purification of 91-6 glucanase (pool no. 1, pooled fractions 4 and 5 from the cation exchange chromatography experiment; figure 1) by gel filtration chromatography. l1-6 glucanase activity elutes from the column at fractions 24-26.

25 Protein is measured at A280 and is depicted in milli-absorption units. R1-6 glucanase activity is measured as described and i.

depicted as the absorbance at 510 nanometre.

Figure 3. SDS-PAGE analysis of the protein fractions of pool no.

30 after gel filtration chromatograpny (figure 2).

Figure 4. Purification of 91-6 glucanase (pool no. 1. pooled fractions 25 and 26 from the gel filtration chromatography experiment; figure 2) by chromacophocusing chromatography on a Mono P exchanger column. 91-6 glucanase activity elutes from the column at fractions 11-12. corresponding to a pH of about 6.7. Protein is measured at A280 and is depicted in milli-absorption units.

Figure 5. SDS-PAGE analysis of the 31-6 glucanase activity containing fractions of pool no. 1 after chromatophocusing chromatography (figure 4).

Figure 6. Purification of I1-6 glucanase (pool no. 2. pooled fractions 10, 11. and 12 from the cation exchange chromatography experiment; figure 1) by gel filtration chromatography. 91-6 glucanase activity elutes from the column at fractions 15-17.

Protein is measured at A280 and is depicted in milli-absorption units. 31-6 glucanase activity is measured as described and is depicted as the absorbance at 510 nanometre.

Figure 7. SDS-PAGE analysis of the protein fractions of pool no. 2 after gel filtration chromatography (figure The arrow points towards the presumed l1-6 glucanase bands.

Figure 8. Purification of 31-6 glucanase (pool no. 2, traction 16 from the gel filtration chromatography experiment.; figure 6) by chromatofocusing chromatography on a Mono P exchanger colurji. 1i-6 glucanase activity elutes from the column at fractions corresponding to the flow-through of the column. meaning that the isoelectric point is above pH 6.8. Protein is measured at A280 and is depicted in milli-absorption units.

25 Figure 9. SDS-PAGE analysis of the 1.1-6 glucanase activity containing fractions of pool no. 2 after chromatophocusing chromatography (figure The arrow points towards the :1-6 glucanase band.

S* 30 Figure 10. Purification of r1-6 glucanase (pool no. 3. pooled ~fractions 15. 16. and 17 from the cation exchange chromatography experiment; figure 1) by gel filtration chromatography. 31-6 o. glucanase activity elutes from the column at fractions 15-18.

So*: Protein is measured at A280 and is depicted in milli-absorption units. 61-6 glucanase activity is measured as described and is depicted as the absorbance at 510 nanometre.

a a Figure 11. Double reciprocal plot showing 3,1-6 glucanase activity as a function of pustulan concentration. Fraction number 4 frorn the chromatophocusing column from pool no. 2 (figure 8) was used as source of P.1-6 glucanase activity. Bl,-6 glucanaso activity is; measured as described and is depicted as the absorbance at 510 nanometre.

Figure 12. Effect of AP24 and ZI-6 glucanasc on in vitro arowth ot Fusarium oxysporum The fungus was grown in a microt.-ter plate assay as described, in the presence of 5pg/ml AP24 plus 51tginm I glucanase (91-6/AP!.4) or in the absence of these proteins (Ref) Fungal growth was followed in time by reading the absorban~ce a~t 620 nanometres in a microtiter plate reader.

Figure 13. Effect of AP24 and E,1-6 glucanase on. in vitr-' crowJt 0 Paccilomyces variottil. Same assay as depicted in fiq. Figure 14. Effect of AP24 and 91-6 glucanase on in vitro arowth of Penicillium roquetorti. Same assay as depicted in fig. 12.

DETAILED DESCRIPTION OF THE INVENTION The (S-(1.6)-glucanase protein according Lo the present invention may be obtained by isolating it troin any suitable- *:-ilble fungus source material containing it. Edible fungi in this respct means fungi which are commonly eaten. A particularly suitable source comprises fruit bodies and or mycelium of mnushroom.!; *(Aqaricus spp. oyster mushrooms (Plcurotw.; occrrus). s"i cakc (Lentinus edodes) or of other commonly eaten tuncii such as ~Volvariella spp., Tricholorma macsutake. Tuber tuncinaLLM.,2ae nielanosporum. Tuber spp. Scephensia spp.. Cantharel Ius spp..

.Plaurotus spp.., Coprinus spp.., Lepiota spp. Marasmius spp.., Polysporus spp.. Verpa spp.. Tricholorro spp.., Trrtczia spp..

Morchella spp.. Cyttaria spp and fungi routinely used in the production of cheese such as Penicillium roqueforti1 and P.

camemberti.

Alternatively, proteins according to the invention may be obtained by cloning DNA comprising an open reading frame capable of encoding said protein, or the precursor thereof, linking said open reading frame to a transcriptional, and optionally a translational initiation and transcriptional termination region, inserting said DNA into a suitable host cell and allowing said host cell to produce said protein. Subsequently, the protein may be recovered from said host cells, preferably after secretion of the protein into the culture medium by said host cells. Alternatively, said host cells may be used directly in a process of combating fungal pathogens according to the invention as a posticidal acceptable composition.

Host cells suitable for use in process of obtaining a protein according to the invention may be selected trom prokaryotic microbial hosts, such as bacteria e.g. Agrobacteriu. Bacillus, Cyanobacteria, E.coli Pscudomonas. and the like. as well as eukaryotic hosts including yeasts. e.g. Saccharonmyces corce: siae.

fungi, e.g. Trichoderma and plant cells, including pro.toplasts.

The word protein means a sequence of am:no acids connected trough peptide bonds. Polypeptides or peptides are also considered to be proteins. Muteins of the protein of the inventon are proteins that are obtained from the proteins depicted in the sequence listing by replacing, adding and/or deleting one or more amino acids, while still retaining their glucanase activity. Such 25 muteins can readily be made by protein engineering vivo. e.g. by changing the open reading frame capable of encoding the protein such that the amino acid sequence is thereby affected. As long as the changes in the amino acid sequences do not altogether aboli.h the glucanase activity such mutei.s are embraced in the present 30 invention.

The present invention provides a chimeric DNA sequence which comprises an open reading frame capable of encoding the protein according to the invention or a combination of osmotin and glucanase. The expression chimeric DNA sequence shall mean to comprise any DNA sequence which comprises DNA sequences not naturally found in nature. For instance, chimeric DNA shall mean to comprise DNA comprising the said open reading frame in a nonnatural location of the host genome. notwithstanding the fact that said host genome normally contains a copy of the said open reading frame in its natural chromosomal location. Similarly, the said open reading frame may be incorporated in the host genome wherein it is not naturally found, or in a replicon or vector where it is not naturally found, such as a bacterial plasmid or a viral vector.

Chimeric DNA shall not be limited to DNA molecules which are replicable in a host, but shall also mean to comprise DNA capable of being ligated into a replicon. for instance by virtue of specific adaptor sequences, physically linked to the open reading frame according to the invention. The open reading frame may or may not be linked to its natural upstream and downstream regulatory elements.

The open reading frame may be derived from a genomic library.

In this latter it may contain one or more introns separati:ng the exons making up the open reading frame that encodes a protein according to the invention. The open reading frame may also be encoded by one uninterrupted exon. or by a cDNA to the mRNA encoding a protein according to the invention. Open reading frames according to the invention also comprise those in which one or more introns have been artificially removed or added. Each of these variants is embraced by the present invention.

The open reading frame coding for the osmotin preferably comprises a nucleotide sequence that codes for a protein as is depicted in SEQ ID NO:2. Most preferably the nucleczide sequence comprises the nucleotide sequence of the open reading frame depicted in SEQ ID NO:l.

The open reading frame coding for the f-(i.6)-glucanase can eithez be composed of the sequence coding for the protein which can be derived from Trichoderma harzianuri, or it can be derived from an edible fungus or a plant.

In order to be capable of being expressed in a host cell a chimeric DNA according to the invention will usua ly be provided with regulatory elements enabling it to be recognised by the biochemical machinery of the host and allowing for the open reading 35 frame to be transcribed and/or translated in the host. It will usually comprise a transcriptional initiation region which may be suitably derived from any gene capable of being expressed in the host cell of choice, as well as a translational initiation region for ribosome recognition and attachment. In eukaryotic cells, an expression cassette usua.Uy comprises in addition a transcriptional termination region locatedciownstream of said open reading frame.

allowing transcription to terminate and polyadenylation of the primary transcript to occur. In addition, the codon usage may be adapted to accepted codon usage of the host of choice. The principles governing the expression of a chimeric DNA construct in a chosen host cell are commonly understood by those of ordinary skill in the art and the construction of expressible chimeric DNA t0 constructs is now routine for any sort of host cell. be it prokaryotic or eukaryotic.

In order for the open reading frame to be maintained in a host cell it will usually be provided in the form of a replicon comprising said open reading frame according to the invention linked to DNA which is recognised and replicated by the chosen host cell. Accordingly the selection of the replicon is determined largely by the host cell of choice. Such principles as govern the selection of suitable replicons for a particular chosen host are well within the realm of the ordinary skilled person in the art.

A special type of replicon is one capable of transferring itself, or a part thereof, to another host cell, such as a plant cell. thereby co-transferring the open reading frame according to the invention to said plant cell. Replicons with such capability are herein referred to as vectors. An example of such vector is a Ti-plasmid vector which, when present in a suitable host, such as Agrobacterium cumefaciens, is capable of transierring part of itself, the so-called T-region. to a plant cell. Different types of Ti-plasmid vectors (vide: EP 0 116 718 LU) are now routine!,' being used to transfer chimeric DNA sequences into plant cells, or 30 protoplasts, from which new plants may be generated which stably incorporate said chimeric DNA in their genomes. A particularly preferred form of Ti-plasmid vectors are the so-called binary vectors as claimed in (EP 0 120 516 BI and US 4.940.838). Other suitable vectors, which may be used to introduce DNA according to the invention into r nlant host. may be selected from the viral vectors. e.g. non-integrative plant viral vectors, such as derivable from the double stranded plant viruses CaMV) and single stranded viruses. gemini viruses and the like. The use of such vectors may be advantageous, particularly when it is difficult to stably transform the plant host. Such may be the case with woody species, especially trees and vines.

The expression "host cells incorporating a chimeric DNA sequence according to the invention in their genome" shall :rean to comprise cells, as well as multicellular organisms comprising such cells, or essentially consisting of such cells, which stably incorporate said chimeric DNA into their genome thereby maintainina the chimeric DNA. and preferably transmitting a copy of such chimeric DNA to progeny cells, be it through mitosis or meiosis.

According to a preferred embodiment of the invention plants are provided, which essentially consist of cells which incorporate one or more copies of said chimeric DNA into their genome, and which are capable of transmitting a copy or copies to their progeny.

preferably in a Mendelian fashion. By virtue of the transcription and translation of the chimeric DNA according to the invention in some or all of the plant's cells, those cells as produce the antifungal proteins will show enhanced resistance to fungal infections. Although the principles as govern transcription of DNA in plant cells are not always understood, the creation of chimcric DNA capable of being expressed in substantially a constitutive fashion, that is. in substantially most cell types of the plant and substantially without serious temporal and/or developmental restrictions, is now routine. Transcription initiaticn regions routinely in use for that purpose are promoters obtainable trom the cauliflower mosaic virus, notably the 35S PNA and 19S RNA transcript promoters and the so-called T-DNA promoters of .:Agrobacterium t.umefaciens. in particular to be mentioned are the nopaline synthase promoter, octopine synthase promoter (as 30 disclosed in EP 0 122 791 B1) and the mannopine synthase promoter.

in addition plant promoters may be used. whlich may be substantialiy constitutive, such as the rice actin gene promoter, or e.g. organspecific, such as the root-specific promoter. Alternatively.

pathogen-inducible promoters may be used such as the PRPI promoter 35 (also named gstl promoter) obtainable from potato (Martini N. er al. (1993). Mol. Gen. Genet. j. 179-186). The choice of the promoter is not essential, although it must be said that .constitutive high-level promoters are slightly preferred. it is a:cntttv ihlvlpooer r lgtypeerd ti further known that duplication of certain elements. so-called enhancers. may considerably enhance the expression level of the DNA under its regime (vide for instance: K~ay R. et (1987). Science 21k, 1299-1302: the duplication of the sequence between -343 and S 90 of the CaMV 35S promoter increases the activity o! that promoter) In addition to the 35S promoter. singly or eo%;bly enhanced, examples of high-level promoters are the light- indc:Hc ribulose bisphosphate carboxylase small subunit (rb1cSS*J) promoter and the chlorophyll a/b binding protein (Cab) promoter. Also envisaged by the present invention are hybrid promoters. wOich comprise elements of different promoter regions physiczilly linkedJ.

A well known example thereof is the so-called CaYV enhanced mannopine synthase promoter (US Patent 5.106,'739). which comr riscs elements of the mannopine synthase promoter linked to the Cal-r, enhancer.

As regards the necessity of a transcriptional termiatcr region. it is generally believed that such a region enhances the reliability as well as the efficiency of transcr:ption in plan: cells. Use thereof is therefore strongly preferred n he contexi.

of the present invention.

Another aspect of gene expression in transclen:c plants concerns the targeting of antifungal proteins to the exi.-acel'.ar *space (apoplast) Naturally intracellularly occxurrina protein..

among which proteins according to the present ::ivent'-.on. may be 25 caused to be targeted to the apoplast by removal c!f the C-termrinal propeptide. e.g. by modifying the open reading :rame at its 3, end -VOO: such that protein is caused to be C-terininally trunca:ted. c,.r--ai: n.umrber of amin~o acids of the C-terminal part. of thie -protoi: was found to be responsible for targeting of the protein. :o th vacuo~t: vide %10911.8984 Al). By introducing a translat~cra stcp-et-oo in the open reading frame the truncated protein is caused o b." targeted to the apoplast.

The invention can be practiced in all plants, even-,. plant species that are presently not amenable for transformation. as the amenability of such species is just a matter o: time and because tran~sformation as such is of no relevance for the prin~ciples underlying the invention. Hence, plants for the purpose ot this description shall include angiosperms as well as gymnosperms, monocotyledonous as well as dicotyledonous plants, be they for feed, food or industrial processing purposes; included are plants used for any agricultural or horticultural purpose including forestry and flower culture, as well as home gardening or indoor gardening, or other decorative purposes.

Transformation of plant species is now routine for an impressive number of plant species, including both the Dicotyledoneae as well as the Monococyledoneae. In principle any transformation method may be used to introduce chimeric DNA according to the invention into a suitable ancestor cell. Methods may suitably be selected from the calcium/polyethylene glycol method for protoplasts (Krens. F.A. et al.. 1982. Nature 296. 72- 74; Negrutiu I. ec al. June 1987. Plant Mol. Biol. S. 363-373).

electroporation of protoplasts (Shillito R.D. et al.. 1985 Bio/Technol. 1099-1102), microinjection into plant material (Crossway A. et al.. 1986. Mol. Gen. Genet. 2Q2. 179-185), (DNA or RNA-coated) particle bombardment of various plant material (Klein T.M. et al.. 1987. Nature 132. 70), infection with (nonintegrative) viruses, in planta Agrobacterium tumefaciens mediated gene transfer by infiltration of adult plants or transformation of mature pollen or microspores (EP 0 301 316) and the like. A Spreferred method according to the invention comprises Agrobacterium-mediated DNA transfer. Especially preferred is the use of the so-called binary vector technology as disclosed in EP A 120 516 and U.S. Patent 4.940.838).

Although considered somewhat more recalcitrant towards genetic transformation, monocotyledonous plants are amenable to transformation and fertile transgenic plants can be regenerated 30 from transformed cells or embryos, or other plant material.

Presently. preferred methods for transformation of monocots are micropro)ectile bombardment of embryos, explants or suspeision cells, and direct DNA uptake or (tissue) electroporation (Shimamoto. cc al. 1989. Nature 118. 274-276). Transgenic maize 35 plants have been obtained by introducing the Streptomyces hygroscopicus bar-gene, which encodes phosphinothricin Sacetyltransferase tan enzyme which inactivates the herbicide phosphnothric into embryoenc cls of a maie suspension phosphinothricin)'. into embryoqenic cells of a maize suspension culture by microprojectile bombardment (Gordon-Kamm. 1990. Plant Cell. 2. 603-618). The introduction of genetic material into aleurone protoplasts of other monocot crops such as wheat and barley has been reported (Lee. 1989. Plant Mol. Biol. 1U. 21-30).

Wheat plants have been regenerated from embryogenic suspension culture by selecting embryogenic callus for the establishment of the embryogenic suspension cultures (Vasil. 1990 Bio/Technol. 8.

429-434). The combination with transformation systems for these crops enables the application of the present invention to monocots.

Monocotyledonous plants, including commercially important crops such as rice and corn are also amenable to DNA transfer by Agrobacterium strains (vide WO 94/00977; EP 0 159 418 Bl; Gould J.

Michael D. Hasegawa 0. Ulian EC. Peterson C. Smith RH. (1991) Plant. Physiol. 426-434).

IS To obtain transgenic plants capable of constitutively expressing more than one chimeric gene. a number of alternatives are available including the following: A. The use of DNA. e.g a T-DNA on a binary plasmid, with a number of modified genes physically coupled to a second selectable marker gene. The advantage of this method is that the chimeric genes are physically coupled and therefore migrate as a single Mendelian locus.

B. Cross-pollination of transgenic plants each already capable of expressing one or more chimeric genes, preferably coupled to a 25 selectable marker gene. with pollen from a transgenic plant which contains one or more chimeric genes coupled to another selectable marker. Afterwards the seed, which is obtained by this crossing.

maybe selected on the basis of the presence of the two selectable markers, or on the basis of the presence of the chimeric genes b* 30 themselves. The plants obtained from the selected seeds can afterwards be used for further crossing. In principle the chimeric genes are not on a single locus and the genes may therefore segregate as independent loci.

C. The use of a number of a plurality chimeric DNA molecules. e.g.

35 plasmids, each having one or more chimeric genes and a selectable marker. If the frequency of co-transformation is high. then selection on the basis of only one marker is sufficient. In other ee cases. the selection on the basis of more than one marker is preferred.

12. Consecutive transformation of transgenic plants already containing a first, second, (etc). chimeric gene with new chimeric S DNA, optionally comprising a selectable marker gene. As in method B.the chimeric genes are in principle not on a single locus and the chimeric genes may therefore segregate as independent loci.

E. Combinations of the above mentioned strategies.

The actual strategy may depend on several considerations as maybe easily determined such as the purpose of the parental lines (direct growing. use in a breeding programme, use to produce hybrids) but is not critical with respect to the described invention.

It is known that practically all plants can be regene:.-ated is from cultured cells or tissues. The means for regeneration vary from specie3 to species of plants, but generally a suspension of transformed protoplasts or a petri plate containing transformed explants is first provided. Shoots may be induced directly, or indirectly from callus via organogenesis or embryogenesis and subsequently rooted. Next to the selectable marker, the culture media will generally contain various amino acids and hormones, such as auxin and cytokinins. it is also advantageous to add giutamic acid and praline to the medium, especially for such species as corn and alfalfa. Efficient regeneration will depend on the medium, on the genotype and on the history of the culture. If these three variables are controlled regeneration is usually reproducable and repeatable.

*After stable incorporation of the transformed gene sequences into the transgenic plants, the traits conferred by them can be transferred to other plants by sexual crossing. Any of a number of standard breeding techniques can be used, depending upon the species to be crossed.

To select or screen for transformed cells, it is preferred to include a marker gene linked to the plant expressible gene according to the invention to be transferred to a plant cell. The choice of a suitable marker gene in plant transformation is well within the scope of the average skilled worker: some examples of routinely used marker genes are the neomycin phosphotransferase genes conferring resistance to kanamycin (EP-B 131 623). the glutathion-S-transferase gene from rat liver conferring resistance to glutathione derived herbicides (EP-A 256 223). glutamine S synthetase conferring upon overexpression resistance to glutamine synthetase inhibitors such as phosphinothricin (WO 87/05327). the acetyl transferase gene from Streptomyces viridochromogenes conferring resistance to the selective agent phosphinothricin (EP-A 275 957). the gene encoding a 5-enolshikimate-3- phosphate synthase (EPSPS) conferring tolerance to N-phosphonomethylglycine. the bar gene conferring resistance against Bialaphos WO 91/02071).

the cyanamid hydratase gene and the like. The actual choice of the marker is not crucial as long as it is functional selective) in combination with the plant cells of choice.

IS The marker gene and the gene of interest do not have to be linked, since co-transformation of unlinked genes Patent 4.399.216) is also an efficient process in plant transformation.

Preferred plant material for transformation. especially for dicotyledonous crops are leaf-discs which can be readily transformed and have good regenerative capability (Horsch R.D. et al.. (1985) Science 222. 1229-1231).

Another embodiment of the present invention is an antifungal composition comprising a 6-(1.6)-glucanase and an osmotin. It has been found that both components act synergistically to yield an 25 antifungal effect in vitro. Such antifungal effects are very useful in food applications. Especially low-fat spreads, cheese and other S:,o dairy products, tea-based beverages, fruit- and tomato-based e products are vulnerable food products in this respect. Combinatiions o of antifungal compounds which act synergistically are preferable to

S

combat fungi in food applications because less preservative substance is needed. Furthermore, it is possible to use components from a natural source, which allows reduction of non-natural food additives which is preferable both from a nutritional and from a occupational health viewpoint.

*oo 35 It will be understood that from a regulatory viewpoint it would be preferable to use the 6-(1.6)-glucanase which, as put forward in this invention, can be derived from edible fungi, such as mushrooms and shii-take.

0 oo Beside the active ingredients the composition according to the invention may contain auxiliary ingredients which are usual for fungi combatting compositions and which may include solid diluents, solvents, stabilizers and pH-regulators. The composition may be in the form of a powder, a paste or a liquid, depending on the envisaged way of application.

The composition is particularly suitable as a preservative for combatting fungi in food, but it can be used as well for preventing or combatting undesired fungal growth on other products, such as cosmetic products, where the fungal growth inhibiting composition is not only useful to keep the surface of the cosmetic product soap) free of fungi, but also for an advantageous effect on the skin which is treated with such product, e.g. a shampoo being applied to a scalp with a fungal affliction.

Both the antifungal composition according to the invention as the plant transformed with the gene coding for the protein of the invencion may contain additional antifungal components.

Examples of proteins that may be used in combination with the proteins according to the invention include, but are not limited to. 9-(1.3)-glucanases and chitinases which are ob:ainable from barley (Swegle M. et al.. 1989. Plant Mol. Biol. 12, 403-412; Balance G.M. ec al.. 1976, Can. J. Plant Sci. 5. 459-466 Hoj P.B. ec al.. 1988. FEBS Lett. 230. 67-71; Hoj P.B. et al.. 1989.

Plant Mol. Biol. 11. 31-42 1989), bean (Boller T. et al.. 1983.

Planta 157. 22-31; Broglie K.E. et al. 1986. Proc. Natl. Acad. Sci.

USA i, 6820-6824; V6geli U. ec al.. 1988 Planta 174. 364-372); Mauch F. Staehelin 1989. Plant Cell 1. 447-457); cucumber (Motraux J.P. Boller T. (1986). Physiol. Mol. Plant Pathol. 2fl.

30 161-169); leek (Spanu P. et al.. 1989. Planta 177. 447-455); maize (Nasser W. et al.. 1988. Plant Mol. Biol. 11. 529-538). oat (Fink W. et al.. 1988. Plant Physiol. 270-275). pea (Mauch F. et al.

1984. Plant Physiol. 7. 607-611; Mauch F. et al.. 1988. Plant Physiol. I2. 325-333). poplar (Parsons. T.J. et al. 1989. Proc.

Natl. Acad. Sci. USA 8i. 7895-7899), potato (Gayr.or J.J. 1988.

Nucl. Acids Res. 1. 5210; Kombrink E. ec al. 1908. Proc. Natl.

Acad. Sci. USA 1. 782-786; Laflammne D. and Roxby 1989. Plant Mol. Biol. 13. 249-250),. tobacco Legrand M. at al. 1987.

16 Proc. Natl. Acad. Sci. USA 84, 6750-6754; Shinshi H. et al. 1987, Proc. Natl. Acad. Sci. USA A4, 89-93). tomato (Joosten M.H.A. De Wit P.J.G.M. 1989. Plant Physiol. 12. 945-951). wheat (Molano J. et al.. 1979, J. Biol. Chem. 254, 4901-4907), and the like.

In this context it should be emphasised that plants already containing chimeric DNA capable of encoding antifungal proteins may form a suitable genetic background for introducing chimeric DNA according to the invention, for instance in order to enhance resistance levels, or broaden the resistance. The cloning of other genes corresponding to proteins that can suitably be used in combination with DNA. and the obtention of transgenic plants, capable of relatively over-expressing same, as well as the assessment of their effect on pathogen resistance in planta is now within the scope of the ordinary skilled person ii. the art.

The obtention of transgenic plants capable of expressing, or relatively over-expressing, proteins according to the invention is a preferred method for counteracting the damages caused by pathogens such as fungi, as will be clear from the above description.

Plants, or parts thereof, which relatively over-express the protein combination according to the invention, including plant varieties, with improved resistance against diseases, especially diseases caused by fungi may be grown in the field, in the greenhouse, or at home or elsewhere. Plants or edible parts thereof 25 may be used for animal feed or human consumption, or may be 0,0 processed for food. feed or other purposes in any form of agriculture or industry. Agriculture shall mean to include horticulture, arboriculture. flower culture, and the like.

Industries which may benefit from plant material according to the invention include but are not limited to the pharmaceutical S* industry, the paper and pulp manufacturing industry, sugar manufacturing industry, feed and food industry, enzyme manufacturers and the like.

The advantages of the plants, or parts thereof, according to the 35 invention are the decreased need for fungicide treatment, thus lowering costs of material, labour, and environmental pollution, or prolonging shelf-life of products fruit, seed, and the likei of such plants. Plants for the purpose of this invention shall mean multicellular organisms capable of photosynthesis, and subject to some form of fungal disease. They shall at least include angiosperms as well as gymnospermns. monocotyledonous as well as dicotyledonous plants.

The phrase "plants which relatively over-express a protein, shall mean plants which contain cells expressing a transgeneencoded protein which is either not naturally present in said plant, or if it is present by virtue of an endogenous gene encoding an identical protein, not in the same quantity, or not in the samne cells, compartments of cells. tisrues or organs of the plant. It is known for instance that proteins which normally accumulate intracellularly may be targeted to the apoplastic space.

The following state of the art may be taken into consideration.

especially as illustrating the general level of skill in the art to Is which this invention pertains.

EP-A 392 225 A2; EP-A 440 304 Al: EP-A 460 753 A2; W090/07001 Al; US Patent 4.940.840.

Evaluation of tranagenic plants Subsequently transformed plants are evaluated for the presence of the desired properties and/or the extent to which the desired properties are expressed. A first evaluation may include the level of expression of the newly introduced genes. the level of fungal resistance of the transformed plants, stable heritability of :25 the desired properties, field trials and the like.

Secondly, if desirable, the transformed plants can be crossbred with other varieties, for instance varietieq of hiahe'r commercial value or varieties in which other desired characteristics have already been introduced, or used for the creation of hybrid seeds, or be subject to another round of transformation and the like.

EXPERI4EZTAL PART *35 Standard methods for the isolation, manipulation and amplificat:on of DNA. as well as suitable vectors for replication of recomrbinant DNA. suitable bacterium strains, selection markers, media and the like are described for instance in Haniatis et 41.. molecular cloning: A Laboratory Manual 2nd. edition (1989) Cold Spring Harbor Laboratory Press; DNA Cloning: Volumes I and II Glover ed.

1985); and in: From Genes To Clones Winnacker ed. 1987) Enzyme assay 9(1.6) glucanase activity was determined by measuring the amount of reducing sugars released from pustulan at 37°C. Pustulan was dissolved in hot buffer t50mM Kac. pH 5.0) and, after cooling, remained in solution without precipitation. The standard assay (0.5ml) contained the enzyme preparation. 1.3 mg of pustulan and Kac, pH B(1,3) glucanase activity was assayed with leminarin as the reaction substrate (1.25 mg of laminarin in 0.5ml 50mM NaAc, pH The reducing sugars were determined according to Nelson. N..

J. Biol. Chem. 153. 375-380. 1944.

EXAMPLE 1 Purifiation of 9(1,6) glucanase from edible mushrooms via pustulan precipitation.

It was investigated whether edible mushrooms contained glucanase activity. We were able to demonstrate S-(1.6)-glucanase activity in mushrooms. As a positive control we used a Trichoderma extract that is sold commercially as Novozym 234. This extract is known to contain substantial amounts of (l.6)glucanase enzymatic activity.

30 Table 1 E-(1.6)-glucanase activities in different extracts Sample specific activity (nkat/ma) Agaricus bisporus 1.8 TMV infected 0 tobacco Sunflower 0 Novozvm 234 17 Mushrooms do contain 9-(1,6)-glucanase activity, its specific activity being about one order of magnitude lower compared to the Trichoderma derived enzyme. In protein fractions of sunflower and TMV- infected tobacco no activity could be detected.

Five different mushrooms were tested for 9-(l.6)-glucanase activity and two mushrooms with the highest specific activity were used for purification of the enzyme.

Table 2 Mushroom extract Specific activity (nkat/mg protein) Agaricus bisporus 0.35 Cave mushrooms 0.9 Chestnut mushrooms Oyster mushrooms 1.4 Shii Take 2.6 The newly determined specific activity for the Agaricus bisporus extract is substantial lower than that depicted in table 1. The extract used for the data of Table 2 is a different extract, and we do not know the reason for this discrepancy. The extracts of Oyster mushrooms and Shii Take were used for further purification.

Purification is as follows: An extract of fungi is made by chopping and grinding them in a buffer containing 0.5 M NaAc pH=5.2 0.1% 20 9-mercaptoethanol. then freezing in liquid nitrogen and mincing the .fungi in a blender. Then the crude extract was filtered through layers of cheese cloth. Particles were removed from this solution by centrifugation for 1 hour at 9500 rpm in a Sorvall S-30 rotor.

The crude protein extract (homogenate) was then further purified by ammonium sulfate precipitation, the S-(1.6)-glucanase activity was •precipitated at 80% saturation. The pellet was dialysed into 50 mM NaAc (pH=5.2) buffer. For pustulan adsorption and digestion, this extract was mixed with finely dispersed pustulan particles, incubated for 20 minutes at room temperature, and the mixture centrifuged for 10 minutes at maximum speed in a microfuge a

C*

t centrifuge. Then the pellets were washed twice in 70 mM Potassium phosphate buffer pH 6.0 containing 1 M NaC1. The enzyme was released by overnight incubation of the particles in a buffer containing 50 mM Kac (pH-5.5) in the presence of protease inhibitors and azide to prevent microbial growth. Further purification of the extract was performed by chromatofocusing on a Mono-P column (Pharmacia), in a buffer containing 25 mM imidazole- HCI with a pH gradient of 7.4 to 4.0. Elution of the Oystermushroom enzyme occurred around pH 5.6. The Shii take enzyme eluted at pH 4.5 Data obtained with the mentioned purification scheme are depicted in table 3.

Table 3 Oyster mushrooms Total activity (nkat) Specific activity (nkat/mg) Homogenate 233.5 1.43 AS fraction 134.9 2.22 Pustulan fraction 0.68 Mono-P peak 5.4 >180 Shii Take Homogenate 60.1 2.6 AS fraction 21.1 0.85 Pustulan fraction 0.26 Mono-P oeak 0.46 >230 15 The crude fungi homogenates contain, besides the B-(1,6)-glucanase activity (see above), also 9-(1.3)-glucanase activity and chitinase activity. Specific activities for 9-(1.3)-glucanase are 9.1 and 30.2 nkat/mg for Oyster mushrooms and Shii Take respectively. The oo activities for chitinase are 13.8 and 53.5 OD(550nm) units/mg respectively. The purified proteins (Mono-P fractions) contained no detectable activity for S-(l.3)-glucanase, however, a small amount of chitinase activity was still present.

Both Mono-P peak fractions were subjected to SDS-PAGE. No protein bands were detectable in the Shii Take R-(1.6)-glucanase S25 peak fraction. The Oyster mushroom 9-(1.6)glucanase peakfraction e, contained two closely spaced protein bands of approximately 51kDa after silver staining of the gel. -(1.6)-glucanase from Trichoderma is approximately 43kDa.

Example 2 Purification of 9(1,6) glucanase from edible mushrooms Oyster mushrooms (Pleurocus ostreacus) were homogenized at 4 C in 50mM KAc pH 5.0, 0.1% f-mercaptoothanol (mushrooms buffer 1.5 1 using a Waring blender. The homogenate was centrifuged for 30 minutes at 9,000 g at 4 0 C in a Sorvall SS34 rotor. Subsequently, solid ammonium sulphate was added gradually to a concentration of 2M. Aggregated proteins were removed by centrifugation for 30 minutes at 9.000 g at 4 0 C in a Sorvall SS34 rotor.

Hydrophobic interaction chromatography The supernatant was filtered over a paper filter and applied to a phenyl-sepharose 6FastFlow High sub column (1.6xl5cm) preequilibrated with 2M ammonium sulphate in 50mM potassium-acetate buffer, pH 5.0 at a flow rate of 10 ml/min. The column was washed with at least 10 column volumes of buffer A after which bound protein was eluted with a negative linear gradient ending at potassium acetate buffer pH 5.0. This was followed by a positive 25 gradient starting with 50mM potassium acetate buffer and ended with the same acetate buffer containing 50% ethylene glycol (flow rate ml/min.). Fractions of 10 ml were collected and assayed for S- (1,6)-glucanase activity. Fractions containing 9-(1.6)-glucanase activity were pooled and concentrated in an Amicon ultra-filtration device with a molecular weight cut-off point of 10 kDa.

Cation exchange chromatography The concentrated protein solution was diluted 10 times with sodium acetate buffer pH 4.0 and subjected to cation exchange 35 chromatography on a small Resource S column (Pharmacia). Unbound protein was washed off with 2 column volumes of 25mM sodium acetate buffer pH 4.0. Retained proteins were eluted with a linear gradient ending at 250 mM NaC1 in 25mM sodium acetate pH 4.0 after 40 column ee volumes. Fractions of 2 ml were collected and and assayed for 3- (1.6)-glucanase activity. Three protein peaks containing glucanase activity were found (see fig. Fractions containing these protein peaks were pooled seperately. resulting in three pools (pool no. 1; 2; 3) containing 9-(l.6)-glucanase activity. The pooled protein fractions were brought to pH 5.0 by adding 1/10 volume of 1M potassium acetate pH 5.0. Each pool was concentrated in an Amicon ultra-filtration device with a molecular cut-off point of 10 kDa to about 0.5-1.0 ml.

Gelfiltration chromatography and subsequent chromatofocusing The pools were subjected to gelfiltration chromatography (Superdex 75. 10/30. Pharmacia). with 200mM NaCI in 50mM potassium acetate. pH 5.0 as the running buffer. The sample volume was 200 pl; flow rate 0.5 ml/min. fractions of 0.5 ml were collected.

Pool 1.

The antifungal activity elutes from the gel-filtration colun (fig. 2) at about 12kDa, based on standard marker proteins.

Comparison of the active fractions with the protein pattern on SDS- PAGE (fig. 3) reveals a 40-45 kDa protein as the most likely candidate for 6-(1,6)-glucanase. This result, i.e. the low apparent molecular weight after gel filtration, could be due to an affinity for the column material. It has been reported that fungal cell wall oo hydrolases can display affinity for Sephacryl supports (Cru= de la.

J* et al.. J. Bacteriology 177. No 7. 1864-1871. 1995: Cru: de la.

et al.. Eur. J. Biochem. 206. 856-867. 1992; Tangarore. H. et al.. Appl. Environ. Microbiol. 55. 177-184. 1989) and thus are 30 retarded to a certain extend on a gel filtration column. glucanase containing fractions were pooled, concentrated and subjected to Mono P chromatophocussing chromatography. Starting pH was pH 7.0. Proteins were eluted with a negative pH gradient ending at pH 4.0. The 9-(1.6)-glucanase activity eluted from the column at S 35 pH 6.7 (fig. SDS-PAGE showed one band with an apparent molecular weight of 40-45kDa (fig. Pool 2.

The antifungal activity elutes from the gel-filtration colunn (fig. 6) at about 88kDa. based on standard marker proteins.

Comparison of the active fractions with the protein pattern on SDS- PAGE (fig. 7) did not result in the determination of a single protein band as the most likely candidate for 9-(1.6)-glucanase.

The fraction containing the least protein bands (fraction 16) was subsequently subjected to Mono P chromatofocussing chromatography starting at pH 7.0. Proteins were eluted with a negative p} gradient ending at pH 4.0. The S-(l.6)-glucanase activity was found in the flow-through of the column, indicating an isoelectric point of 6.8 or higher (fig. SDS-PAGE of the S-(1.6)-glucanase containing fractions (fig. 9) showed two bands. Comparison of this gel (fig. 9) with the SDS-PAGE patterns after gel-filtration chromatography (fig. 7) and the respective 9-(l.6)-glucanase activities, showed that S-(1.6)-glucanase corresponds to a protein band with an apparent molecular weight of about 50kDa. This band is indicated with an arrow in fig. 7 and fig. 9. These fractions did not contain 9(1.3) glucanase activity.

Pool 3.

The antifungal activity elutes from the gel-filtration column at the same position as for pool no.2. 88kDa (fig. Kinetic properties of S-(1,6)-glucanase activities.

25 The enzyme activity was measured at different substrate concentrations. A Km of 0.13mg pustulan per ml was calculated (fig.

11). which is about one order of magnitude lower then the KFT.

described for f-(1.6)-glucanase from Trichoderma har=ianun: (Cruz de J. et al.. J. Bacteriology 177. No 7. 1964-1971. 1995: and 30 patent no W095/31534).

ExamPle 3 In vitro antifungal assay on fungi.

35 The antifungal activity of proteins is measured in a microtiter plate assay. Each well of a 96-well microtiter dish contained 75 pl of potato dextrose agar containing 450 spores. The spore solution is added to PDA (0.75% agar. pH 4.9 at 39°C) just *o prior to filling of the microtiterplate wells. On top of this, 75 pi filter sterilized (0.22 (im filter) protein solution is added. The tests are carried out in microtiter plates at 20°C. At several time points after the initiation of incubation the fungus is monitored in a microtiter plate reader at 620 nm.

Synergy in antifungal properties of AP24 and B1-6 glucanase Spores of Fusarium oxysporum, Penicillium roqueforti, or Paecilomyces variottii are used in the antifungal assays. AP24 or f1-(1-6)-glucanase from Trichoderma harzianum are added separately at a final concentration of 5 Ig/ml or are added in combination (5 jIg/ml of each). AP24 was purified according to W091/18984. R-(1-6)-glucanase was purified from a Pichia pastoris expression system according to Lora, J.M. et al., Mol. Gen. Genet., 247, 639-645, 1995; Bom, I.J. et al., Biochim. Biophys. Acta, General subjects, submitted 1998.

AP24 alone or 1-(1-6)-glucanase alone did not result in inhibition of fungal growth. AP24 in combination with (1-(1-6)-glucanase (5 jig/ml of each) resulted in strong inhibition of fungal growth (see figures 12, 13, 14).

Throughout the description and claims of this specification, the word "comprise" and variations of the word, such as "comprising" and "comprises", is not intended to exclude other additives, components, integers or steps.

20 The discussion of documents, acts, materials, devices, articles and the like is included in this specification solely for the purpose of providing a context for the present invention. It is not suggested or represented that any or all of these matters formed part of the prior art base or were common general knowledge in the field relevant to the present invention as it existed in Australia before the priority date of each claim of this application.

o* *e* e MR C:\WINWORD\MARYNODELETE\776O8.DOC Page(s)3D- 'S are claims pages they appear after the sequence listing SEQUENCE LISTING GENERAL INFORMATION:

APPLICANT:

NAME: MOGEN International nv STREET: Einsteinweg 97 CITY: Leiden 1 0 COUNTRY: The Netherlands POSTAL CODE (ZIP): 2333 CB TELEPHONE: (31)-71-5258282 TELEFAX: (31)-71-5221471 (ii) TITLE OF INVENTION: Antifungal composition, and hosts incorporating same.

(iii) NUMBER OF SEQUENCES: 2 (iv) COMPUTER READABLE

FORM:

MEDIUM TYPE: Floppy disk COMPUTER: IBM PC compatible OPERATING SYSTEM: PC-DOS/MS-DOS SOFTWARE: PatentIn Release Version #1.25 (EPO) INFORMATION FOR SEQ ID NO: 1: SEQUENCE CHARACTERISTICS: LENGTH: 741 base pairs TYPE: nucleic acid STRANDEDNESS: double TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO (iii) ANTI-SENSE: NO i* (vi) ORIGINAL SOURCE: ORGANISM: Nicotiana tabacum (vii) IMMEDIATE SOURCE: S 45 CLONE: pMOG404 (ix) FEATURE: NAME/KEY:

CDS

LOCATION: 1..739 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 1: ATG GGC AAC TTG AGA TCT TCT TTT GTT TTC TTC CT Met Cly Asn Leu Arg Ser Ser Phe Val Phe Phe Le 1 5 10 ACT TAT ACT TAT GCT GCC ACT ATC GAG GTC CGA A; Thr Tyr Thr 1yr Ala Ala Thr Ile Giu Val Arg As 25 ACC OTT TOO CCG CCG TCG ACA CCC ATA GCC GOT GC Thr Val Trp Ala Ala Ser Thr Pro Ile Gly Gly G: 40 CGA GGC CAA ACT TGG GTG ATC AAT GCG CCA COA G( Arg Gly Gin Thr Trp Val Ile Asn Ala Pro Arg G 55 CGT GTA TGG GGC CGT ACT AAT TOT AAC TTC AAT G Arg Val Trp Cly Arg Thr Asn Cys ASn Phe Asn A 70 75 ACO TGC CAA ACC GGT GAC TOT GGT GGA GTC CTA C Thr Cys Gin Thr Gly Asp Cys Gly Gly Val Leu G 85 90 GOT AAA CCA CCA AAC ACC TTG GCT GAA TAC GCT Gly Lys Pro Pro Asn Thr Leu Ala Giu Tyr Ala I 100 105 GGT TTA GAT TTC TGG GAC ATT TCT TTA. GTT GAT( Gly Leu Asp Phe Trp Asp Ile Ser Leu Val Asp 115 120 ATO ACT TTC CC CCC ACT AAC CCT AGT GGA CG Met Thr Phe Ala Pro Thr Asn Pro Ser Gly Gly 130 135 CAT TOT ACG OCT AAT ATA AAC CCC GAA TOT CCC His Cys Thr Ala Asn Ile Asn Giy Giu Cys Pro 145 150 155 CCC GGA OCA TOT AAT AAC CCT TOT ACT ACA TI'C Pro Oly Cly Cys Asn Asn Pro Cys Thr Thr Phe 165 170 TOT TOC ACA CAA COA CCT TOT OCT CCT ACA TTT Cys Cys Thr Gin Cly Pro Cys Gly Pro Thr Phe 180 185 AAA CAA AGA TGC CCT CAT CCC TAT ACC TAC CCA Lys Gin Arg Cys Pro Asp Ala Tyr Ser Tyr Pro 195 200 AGC ACT TTT ACT TOC CCT GOT COT ACT ACA MAT Ser Thr Phe Thr Cys Pro Oly Gly Ser Thr Asn 210 215 'C CTT CCC TT .u Leu Ala Le 1 ~C MAC TOT CC ~n Asn Cys Pr ;C COG COT C ly Arg Arg Lc ACT AMA A ly Thr Lys M4 CT OCT COT A la Ala Cly A AG TOC ACC C In Cys Thr C TG CAC CM A .eu Asp Gin P 110 ;GA TTC MAC3 31y Phe Asn 125 AAA TOC CAT Lys Cys His 140 CCC GMA CTT Arg Oiu Leu GCA GGA CMA Giy Giy Gin TTC TCA MA Phe Ser Lys 190 CMA CAT CAT Gin Asp Asp 205 TAT AGO OTT Tyr Arg Val 220 GC GTO u Val G TAC ~o Tyr P'C CAT eu Asp et Ala rg Cly CO TOO ly Trp TC ACT ~he Scr .T T CCC Ilie Pro GCA ATT Ala Ile AGO OTT Arg Val 160 CMA TAT Gin Tyr 175 TTT TTC Phe Phe CCT ACT Pro Thr ATC TTT Ile Phe 48 96 144 192 240 288 336 384 432 480 528 576 624 672

S

TOT

Cys 225

SACT

Ser CCT AAT GGT CAA Pro Asn Gly Gin GAT GAA GTG GCT Asp Giu Val Ala 245 GCT CAC CCA AAT TTT CCC TTG GAA ATG CCT GGA Ala His Pro Asn Phe Pro Leu Glu Met Pro Gly 230 235 240 AAG T AG Lys INFORMATION FOR SEQ ID NO: 2: SEQUENCE CHARACTERISTICS: LENGTH: 246 amino acids TYPE: amino acid TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 2: Met Gly Asn Leu Arg 5cr Scr Phe Val Phe Phe Leu Lou Ala Leu Val 1 5 10

S.

S

S

S

S

S

S Thr Thr Arg Arg Thr Gly Gly Met His 145 Pro Cys Lys Ala Ser Val Thr 70 Asp Thr Asp Thr Ile 150 Asn Pro Asp Val1 Gly Pro Phe Val 90 Tyr Val1 Gly Cys Thr 170 Thr Arg Gly Arg Asn Leu Al a Asp Gly Pro 155 Phe Phe Asn Gly Gly Ala Gin Leu Gly Lys 140 Arg Gly Phe Asn Cys Pro Arg Arg Leu Thr Lys Met Ala Gly Arg Cys Thr Gly Asp Gin Phe 110 Phe Asn Ile 125 Cys is Ala Giu Leu Arg Gly Gin Gin 175 Ser Lys Phe 190 Asp Pro Thr Tryr Pro Gin Asp 205 Ser Thr Phe Thr Cys Pro Gly Gly Ser Thr Asn Tyr Arg Val Ile Phe 210 215 220 Cys Pro Asn Gly Gin Ala His Pro Asn Phe Pro Leu Glu Met Pro Gly 225 230 235 240 Ser Asp Giu Val Ala Lys 245 29

Claims (13)

1. Antifungal composition comprising a p-(1,6)-glucanase and an osmotin.

2. Antifungal composition according to claim 1, wherein the osmotin has an amino acid sequence as depicted in SEQ ID NO:2.

3. Method for the production of pathogen resistant plants by transforming them with a chimeric DNA comprising a sequence coding for a glucanase and a chimeric DNA comprising a sequence coding for an osmotin.

4. Method according to claim 3, wherein the osmotin comprises the amino acid sequence of SEQ ID NO:2.

5. Method according to claim 4, wherein the sequence coding for the osmotin comprises the nucleotide sequence of SEQ ID NO:1.

6. Method according to any one of claims 3 to 5, wherein the glucanase is of fungal origin.

7. Method according to claim 6, wherein the fungus is Trichoderma harzianum.

8. Method according to claim 6, wherein the fungus is an edible mushroom.

9. Method according to claim 8, wherein the fungus is selected from the group consisting of Lentinus edodes, Volvariella spp., Tricholoma matsutake, Agaricus spp., Tuber uncinatum, Tuber melanosporum, Tuber spp., Stephensia spp., Cantharellus spp., Pleurotus spp., Coprinus spp., Lepiota spp., Marasmius spp., Polysporus spp., Verpa spp., Tricholma spp., Terfezia spp., Morchella Si spp., Cyttaria spp and fungi routinely used in the production of cheese such as Penicillium roqueforti and P. camemberti.

C:\My Documents\sharonj\77608-claims.doc 31 Method according to claim 9, wherein the p-(1,6)-glucanase, has a molecule weight of about 50-51 kD and a pi of about 6.7-6.8 or higher.

11. Method according to any one of claims 3 to 10 wherein the osmotin or the p-(1,6)-glucanase is targeted to the extracellular space.

12. Method according to any one of claims 3 to 10, wherein the plants are also transformed with a sequence coding for a protein selected from the group consisting of chitinases, P-(1,3)-glucanases, chitobiases, N-acetyl-p- glucosaminidases, basic PR-1, antifungal proteins (AFP's), phospholipase B, proteases, defensins, cecropins, thionins, mellitins, magainins, attacins, dipterins, cacrutins, xenopsins, and hybrids thereof.

13. A method according to claim 1 substantially as hereinbefore described. DATED: 21 November, 2001 PHILLIPS ORMONDE FITZPATRICK Attorneys for: MOGEN INTERNATIONAL NV go. C:\My Documents\shamnj\77608-claims.doc